Orbotech set to buy Danish diagnostics firm
This article was originally published in Clinica
Imaging solutions specialist Orbotech (Yavne, Israel) has signed a definitive agreement to buy 3D-Danish Diagnostic Development (DDD) in a deal worth around $39m, plus an earn-out, capped at $6.5m. The transaction will see Orbotech acquire all outstanding shares of DDD, in a bid to diversify into the medical imaging market.
You may also be interested in...
Medical products that do not fully comply with Canadian requirements but are manufactured according to comparable standards are being allowed into the country to deal with COVID-19-related shortages.
A randomized COVID-19 study spanning the whole of the UK could help to bolster the UK’s reputation as a location for future clinical trials. It is also being seen partly as the result of the UK regulator's "decisive action" in fast-tracking trials for potential COVID-19 therapies.
Manufacturers of endoscopic equipment, biofeedback devices and thermometers were among those cited for regulatory violations in US FDA warning letters this week. A total of four device-related enforcement missives were released by the agency.